Nixon Peabody Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Nixon Peabody Trust's AMGN Position: Q2 2026 in Review
Nixon Peabody Trust increased its Amgen (AMGN) stake by 9.3% in Q2 2026, buying an estimated $40.4K and bringing the position to 1,381 shares worth $500K. The position accounts for 0.04% of the portfolio, ranked #128.
Nixon Peabody Trust first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Nixon Peabody Trust held 1,381 shares of Amgen worth $500K as of Q2 2026.
- Nixon Peabody Trust bought 118 Amgen shares in Q2 2026, an estimated $40.4K.
- Amgen made up 0.04% of Nixon Peabody Trust's portfolio in Q2 2026, its #128 holding.
- Nixon Peabody Trust first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.